London, UK 10/20/09 and 11/17/09; Manchester, UK 10/19/09—Millbrook Scientific Instruments, maker of the NanoTest nanomechanical test system, has delisted its stock from London’s AIM exchange. The company sought to cancel its listing in order to reduce costs, limit competitive exposure and reduce the time burden on management. The company has also changed its name to […]
Sequential improvements in quarterly revenue growth provided some good news for major, publicly held analytical and life science instrument and laboratory product companies in the calendar-year third quarter. But despite the trend, revenues were down year over year for seven of the nine companies whose results are presented in the table on page 10. Fourth-quarter […]
In the third quarter of 2009, revenues for IBO’s Laboratory Instrument Sales Index declined 3.0% to $4,405.53 million, while operating profit decreased 2.3% to $762.90 million. Operating margin slipped 10 basis points to 17.3% of sales. For the three companies (Oxford Instruments, Shimadzu and Tecan) that did not report earnings before this issue’s publication, modest […]
Extreme market fluctuations once again reigned as investors questioned the sustainability of the US economic recovery. Worse than expected manufacturing and unemployment data were reported, but on October 14, the Dow surpassed the 10,000 level for the first time in over a year. On October 29, the Commerce Department announced that the US grew at […]
Sunnyvale, CA 10/28/09—Symyx Technologies has announced the restructuring of its High Productivity Research business (HPR), resulting in the termination of 75 employees. The company will shut down its contract development and manufacturing operations that were acquired as part of its acquisition of contract service provider Integrity Biosolution last year (see IBO 8/15/09). Consequently, it will […]
As the US begins to roll out its fiscal 2010 appropriations, IBO takes a look at the Department of Energy (DOE), Department of Agriculture (USDA) and Department of Homeland Security (DHS) budgets. Currently, seven appropriation bills are still being voted on by the Senate or are in conference. These departments are operating at fiscal 2009 […]
Spending on Science and Engineering (S&E) R&D at US universities and colleges increased 4.8% last fiscal year (ended September 30, 2008) to $51,909 million, according to the latest figures from the National Science Foundation (NSF). Adjusted for inflation, academic S&E R&D spending rose 2.3%. Funding for basic research grew 4.1% to $39,408 million. Applied R&D […]
Second-quarter revenues for IBO’s Lab Equipment/Consumables Sales Index contracted 6.7% to $853.8 million, and operating profits declined 6.1% to $259.2 million. Adjusted operating margins improved 30 basis points to 30.4% of sales. Biohit’s second-quarter sales declined 5% to €8.7 million ($11.9 million = €0.73 = $1), while operating income plunged 38% to €0.2 million ($0.3 […]
London, England 9/22/09, London, England 10/6/09—Millbrook Scientific Instruments has placed its subsidiary that manufactures the MiniSIMS (secondary ion MS) system into administration in order to conserve cash.
Cambridge, MA 9/16/09—Helicos Biosciences has raised approximately $9.4 million through a private placement of common stock and warrants. Purchasers include four existing investors, as well Ron Lowy, Helicos’s CEO, a new investor. In early September, the company announced it is considering strategic alternatives (see IBO 9/15/09).
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
